Add like
Add dislike
Add to saved papers

Biogeochemical oxidation of calcium sulfite hemihydrate to gypsum in flue gas desulfurization byproduct using sulfur-oxidizing bacteria.

Flue gas desulfurization (FGD) is a well-established air treatment technology for coal and oil combustion gases that commonly uses lime or pulverized limestone aqueous slurries to precipitate sulfur dioxide (SO2 ) as crystalline calcium salts. Under forced oxidation (excess oxygen) conditions, FGD byproduct contains almost entirely (>92%) gypsum (CaSO4 ·2H2 O), a useful and marketable commodity. In contrast, FGD byproduct formed in oxygen deficient oxidation systems contains a high percentage of hannebachite (CaSO3 ·0.5H2 O) to yield a material with no commercial value, poor dewatering characteristics, and that is typically disposed in landfills. Hannebachite in FGD byproduct can be chemically converted to gypsum; however, the conditions that support rapid formation of gypsum require large quantities of acids or oxidizers. This work describes a novel, patent pending application of microbial physiology where a natural consortium of sulfur-oxidizing bacteria (SOB) was used to convert hannebachite-enriched FGD byproduct into a commercially valuable, gypsum-enriched product (US Patent Assignment 503373611). To optimize the conversion of hannebachite into gypsum, physiological studies on the SOB were performed to define their growth characteristics. The SOB were found to be aerobic, mesophilic, neutrophilic, and dependent on a ready supply of ammonia. They were capable of converting hannebachite to gypsum at a rate of approximately five percent per day when the culture was applied to a 20 percent FGD byproduct slurry and SOB growth medium. 16S rDNA sequencing revealed that the SOB consortium contained a variety of different bacterial genera including both SOB and sulfate-reducing bacteria. Halothiobacillus, Thiovirga and Thiomonas were the dominant sulfur-oxidizing genera.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app